by In2Pharma | Oct 12, 2026 | News
Belgium A recent update of the NDS-web platform has been implemented by the FAMHP. The update introduces several changes and new functionalities that may impact companies involved in the import and export of narcotic and psychotropic drugs. Key changes include:...
by In2Pharma | Oct 9, 2026 | News
Luxembourg The Grand-Ducal Regulation of 11 December 2003 on food supplements has been amended by the Grand-Ducal Regulation of 27 July 2026, which entered into force in August 2026. The amendment revises the maximum permitted levels for several vitamins and minerals...
by In2Pharma | Oct 1, 2026 | News
The Netherlands The Dutch Minister of Health, Welfare and Sport (VWS) has approved the indexation of the maximum hospitality limits applicable to educational events and manifestations. Following consultations between the GMH, the CGR and the Ministry of Health,...
by In2Pharma | Oct 1, 2026 | News
The Netherlands The CGR has published the updated reasonable maximum hourly rates for services provided by healthcare professionals. The new rates will enter into force on 1 January 2027 and are based on the annual indexation. Companies engaging healthcare...
by In2Pharma | Oct 1, 2026 | News
The Netherlands As of 1 August 2026, the GAIA self-assessment on hospitality and sponsorship compliance is also fully applicable to medical device companies. When hospitality offered to participants during educational events is funded by medical device and/or...
